A Survey of Public Attitudes Toward Glaucoma Screening

  • Research type

    Research Study

  • Full title

    A Survey of Public Attitudes Toward Glaucoma Screening

  • IRAS ID

    352367

  • Contact name

    Andrew Tatham

  • Contact email

    andrew.tatham@nhs.scot

  • Sponsor organisation

    University of Edinburgh

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    0 years, 2 months, 31 days

  • Research summary

    This study is a UK-wide survey designed to explore public attitudes toward screening for glaucoma, an eye condition that can lead to permanent vision loss. Glaucoma usually develops slowly and without symptoms, meaning many people do not realise they have it until significant damage has occurred. Early detection through screening could help prevent vision loss, but little is known about what encourages or discourages people from taking part in glaucoma screening.

    The study will involve adults aged 18 and over living in the United Kingdom. Participants will be invited to complete a one-time, anonymous online survey, which takes around 10–15 minutes. The survey will collect information about people’s awareness of glaucoma, their previous experiences with health screening and eye care, their family history, and their views on screening and the use of new technologies such as artificial intelligence (AI) and genetic information in healthcare.

    People will be able to take part by scanning a QR code or following a web link found on posters and flyers in locations such as GP practices, optometrists, pharmacies, and NHS Lothian websites. No medical records will be accessed, and no identifiable information will be collected unless participants voluntarily provide an email address to receive results or take part in future studies. Consent will be implied by completing the survey.

    The findings from this research will help guide the development of future glaucoma screening programmes. They will highlight what matters most to the public, including any concerns about technology, privacy, or access. This could support earlier diagnosis and treatment of glaucoma, helping to prevent avoidable sight loss and improve public health outcomes.

  • REC name

    London - Camden & Kings Cross Research Ethics Committee

  • REC reference

    25/PR/1085

  • Date of REC Opinion

    21 Aug 2025

  • REC opinion

    Favourable Opinion